SCHEMBL8401307

SCHEMBL8401307

CCC(=O)Nc1cc(OCc2ccncc2)cc2cccnc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.49
HDAC6 Q9UBN7 3/20 0.47
MEN1 O00255 5/20 0.47
MAPT P10636 4/20 0.47
LMNA P02545 2/20 0.47
ALDH1A1 P00352 3/20 0.46
HTT P42858 1/20 0.46
ERBB4 Q15303 1/20 0.46
SLC40A1 Q9NP59 1/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC8 Q9BY41 1/20 0.45
HPGD P15428 2/20 0.44
TSHR P16473 1/20 0.44
TP53 P04637 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
POLB P06746 2/20 0.42
TMEM97 Q5BJF2 1/20 0.41
SIGMAR1 Q99720 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8401286 0.92 SLC40A1 (0.51) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL8404193 0.89 KMT2A (0.47) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL8110856 0.86 KMT2A (0.48) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL8401300 0.84 EGFR (0.49) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL8402851 0.83 KMT2A (0.68) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL14345508 0.79 SLC40A1 (0.43) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL5490501 0.79 HDAC6 (0.76) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL8110769 0.78 KMT2A (0.49) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL8103401 0.76 HDAC6 (0.57) KMT2AHDAC6MEN1MAPTLMNA
SCHEMBL8115338 0.75 KMT2A (0.47) KMT2AHDAC6MEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 KMT2A 37/4885HDAC6 11/4885MEN1 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.